Results 31 to 40 of about 2,829 (137)
Remission in schizophrenia: A utopia or a goal?
Psychiatry and Clinical Psychopharmacology, 2021 Remission has provided a realistic treatment goal in mood and anxiety disorders and led to an improved understanding of the relative benefits of available approaches to treatment.
Sunar Birsöz +4 more
doaj
Bir devlet hastanesinde psikiyatri dışı benzodiazepin kullanımı
Psychiatry and Clinical Psychopharmacology, 2021 Bir devlet hastanesinde psikiyatri dışı benzodiazepin kullanımı Hastane içinde psikiyatri kliniği dışındaki servislerin, benzodiazepin kullanımı/kötüye kullanımını araştırmak amacıyla, İzmir Devlet Hastanesinin dahili ve cerrahi tıp servislerinin ...
İlkin İçelli
doaj
The Bulletin of Legal Medicine, 2019 Purpose:Even though the Forensic Psychiatry is currently defined as a sub-specialty of psychiatry in many countries, current regulations in Turkey does not provide such structured training. In this study, we aimed to evaluate the level of the knowledge of current registered mental health physicians practicing in our country, about forensic psychiatry ...
Çağatay Saygılı +2 more
openaire +1 more source
Efficacy and safety of amisulpride treatment in schizophrenia: Comparison with haloperidol
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Amisulpride is a novel atypical antipsychotic with preferential affinity for presynaptic dopaminergic D2 and D3 receptors. There have been no clinical studies conducted with amisulpride in schizophrenia in Turkey.
Servet Ebrinç +6 more
doaj
THE EFFICACY AND SAFETY OF VENLAFAXINE İN TREATMENT OF MAJOR DEPRESSION
Psychiatry and Clinical Psychopharmacology, 2021 Venlafaxine, a novel antidepressant drug for Turkish population , there are both norepinephrine and serotonin reuptake inhibitory effects. An open study was performed to evaluate the antidepressant efficacy and safety of venlafaxine. Fourthy male and 60
Servet Ebrinç +6 more
doaj
Psychiatry and Behavioral Sciences, 2015 Objective: Is it possible to predict the antidepressant treatment response in patients with major depressive disorder? For the antidepressant treatment, the common belief is to wait 6 weeks for deciding its effectiveness. It seem to be crucial to shorten
Sedar Bulut +3 more
doaj +1 more source
THE EFFICACY AND SAFETY OF HALOPERIDOL AND RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA
Psychiatry and Clinical Psychopharmacology, 2021 Objective: In this study were aimed to compare the efficacy and safety of typical antipsychotic haloperidol and atypical antipsychotic risperidone in patients with schizophrenia.
Servet Ebrinç +4 more
doaj
Differential diagnosis of frontal lobe syndrome: a case report
Psychiatry and Behavioral Sciences, 2016 Frontal lobe syndrome is defined with the Phineas Gage case whose behaviors had changed after injured severely from brain in the 19th century. Until that time, researches about the frontal lobe syndrome is proceeding.
Duriye Gizem Tosun +3 more
doaj +1 more source
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Nefazodone is a novel antidepressant whose efficacy has been demonstrated in the treatment of depression. The present study was planned to evaluate the efficiency and side effect profile of nefazodone, used recently in our country is ...
Murad Atmaca +5 more
doaj
SERUM GONADAL SEX HORMONES OF EARLY-ONSET AND ADULT ONSET SCHIZOPHRENICS: A CONTROLLED STUDY
Psychiatry and Clinical Psychopharmacology, 2021 The role of hormonal differences areimportant in pathophysiology of schizophrenia. There is emerging literature that suggests that neurodevelopment pathology may be more common in male than in female schizophrenics.
Nesrin Dilbaz +2 more
doaj